Morgan Stanley’s Slimmon warns against buying growth-stock dip


Bad start: Monitors display Dow Jones Industrial Average market data outside the Morgan Stanley headquarters in New York. The Nasdaq Composite Index couldn’t have had a messier kickoff to 2022. — Bloomberg

NEW YORK: Investors should avoid the temptation to buy the dips in expensive high-growth stocks because “once the fever breaks, it lasts a long time,” according to Andrew Slimmon, senior portfolio manager at Morgan Stanley Investment Management.

Slimmon joined the “What Goes Up” podcast to discuss what he’s investing in these days. He also explains how the MSIF United States Core Portfolio fund he co-manages beat the S&P 500 with a 36% gain in 2021. Below are the condensed and lightly edited highlights of the conversation.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Morgan Stanley , Andrew Slimmon , stock , buying ,

   

Next In Business News

Trade showing remains on upward trajectory
Maxis pledges full support to government’s 5G delivery model
Fajarbaru Builder secures RM13mil job
MKH Oil Palm IPO oversubscribed
The pros and cons of earned wage access
Making every load lighter
Making the Malaysian startup pitch
How Sin-Kung leveraged air cargo for its success
Domestic office-sector REITs stay cautious
‘Muted optimism’

Others Also Read